IKENA ONCOLOGY INC

CUSIP: 45175G108 Class: Common Stock

Atlas Venture Life Science Advisors, LLC's Holding History (CIK: 0001917529)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 5,018,178 Value ($000) $6,724 Avg Close — Range —
Q1 2025
Shares 5,018,178 Value ($000) $6,423 Avg Close — Range —
Q4 2024
Shares 5,018,178 Value ($000) $8,230 Avg Close — Range —
Q3 2024
Shares 5,018,178 Value ($000) $8,681 Avg Close — Range —
Q2 2024
Shares 5,018,178 Value ($000) $8,280 Avg Close — Range —
Q1 2024
Shares 5,018,178 Value ($000) $7,126 Avg Close — Range —
Q4 2023
Shares 5,018,178 Value ($000) $9,886 Avg Close — Range —
Q3 2023
Shares 5,018,178 Value ($000) $21,729 Avg Close — Range —
Q2 2023
Shares 5,018,178 Value ($000) $32,919 Avg Close — Range —
Q1 2023
Shares 5,018,178 Value ($000) $17,313 Avg Close — Range —
Q4 2022
Shares 5,018,178 Value ($000) $13,348 Avg Close — Range —
Q3 2022
Shares 5,018,178 Value ($000) $17,815 Avg Close — Range —
Q2 2022
Shares 5,018,178 Value ($000) $22,231 Avg Close — Range —
Q1 2022
Shares 5,018,178 Value ($000) $30,611 Avg Close — Range —
Q4 2021
Shares 5,018,178 Value ($000) $62,928 Avg Close — Range —